C. Sanchez

发表

Advances in Brief l 7 p Allelic Losses in Diploid Cells of Patients with Barrett ' s Esophagus Who Develop Aneuploidy '

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2006 .

Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 1993, Gastroenterology.

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

Carissa A. Sanchez, Xiaohong Li, Patricia L. Blount, 2006, Nature Genetics.

Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

David A. Knowles, Lucian P. Smith, Carissa A. Sanchez, 2020, Cell.

NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

Carissa A. Sanchez, Patricia L. Blount, C. Maley, 2013, PLoS genetics.

Evolution of neoplastic cell lineages in Barrett oesophagus

Carissa A. Sanchez, Brian J. Reid, Michael T. Barrett, 1999, Nature Genetics.

Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.

M. Emond, M. Barrett, B. Reid, 1996, Oncogene.

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.

Carissa A. Sanchez, B. Reid, G. Longton, 2000, Journal of the National Cancer Institute.

Selectively Advantageous Mutations and Hitchhikers in Neoplasms

Carissa A. Sanchez, Xiaohong Li, Carlo C Maley, 2004, Cancer Research.

NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma

Kamran Ayub, Carissa A. Sanchez, Xiaohong Li, 2007, PLoS medicine.

1 SNP-based Genome-wide Chromosome Copy Change , LOH , and Aneuploidy in Barrett ’ s Esophagus Neoplastic Progression .

Patricia L. Blount, K. Gunderson, D. Peiffer, 2008 .

Allelic Deletions and p 53 Protein Overexpression in Barrett ' s Adenocarcinoma 1

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2006 .

Biologic Properties of Columnar Epithelium Underneath Reepithelialized Squamous Mucosa in Barrett's Esophagus

Carissa A. Sanchez, Patricia L. Blount, C. Maley, 2005, The American journal of surgical pathology.

Dietary Supplement Use and Risk of Neoplastic Progression in Esophageal Adenocarcinoma: A Prospective Study

A. Kristal, J. Schenk, Linda M. Dong, 2007, Nutrition and Cancer.

17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 1991, Cancer research.

Novel patterns of complex structural variation revealed across thousands of cancer genome graphs

Lucian P. Smith, Julie M. Behr, M. Zody, 2019, bioRxiv.

Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus

A. Kristal, J. Schenk, P. Blount, 2005, Cancer Epidemiology Biomarkers & Prevention.

The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma

Patricia L. Blount, C. Maley, P. Blount, 2004, Cancer Research.

Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis

Carissa A. Sanchez, M. Spitz, Xifeng Wu, 2006, Cancer Epidemiology Biomarkers & Prevention.

Dysplasia and High-Grade

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 1994 .

Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels

P. Martinez, C. Maley, B. Reid, 2018, Nature Communications.

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus

Howard Y. Chang, V. Bafna, R. Verhaak, 2022, bioRxiv.

Somatic whole genome dynamics of precancer in Barrett’s esophagus reveals features associated with disease progression

Lucian P. Smith, Anne-Katrin Emde, M. Imieliński, 2021, Nature Communications.

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.

Carissa A. Sanchez, M. Emond, M. Barrett, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Comparative genomic analysis of tumors: detection of DNA losses and amplification.

Carissa A. Sanchez, M. Wigler, W. M. Linehan, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

P. Blount, B. Reid, P. Rabinovitch, 2001 .

Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.

P. Blount, B. Reid, R. Odze, 2006, Human pathology.

Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array‐CGH

C. Maley, B. Reid, P. Rabinovitch, 2007, Genes, chromosomes & cancer.

Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus

Carissa A. Sanchez, Xiaohong Li, Patricia L. Blount, 2013, Cancer Prevention Research.

Nonadenomatous Dysplasia in Barrett Esophagus: A Clinical, Pathologic, and DNA Content Flow Cytometric Study

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2009, The American journal of surgical pathology.

Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression

Patricia L. Blount, K. Gunderson, D. Peiffer, 2008, Cancer Prevention Research.

Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study

Kamran Ayub, Carissa A. Sanchez, Patricia L. Blount, 2008, Clinical Cancer Research.

Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

Patricia L. Blount, C. Maley, P. Blount, 2007, The American Journal of Gastroenterology.

Chromosomal Instability in Barrett's Esophagus Is Related to Telomere Shortening

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2006, Cancer Epidemiology Biomarkers & Prevention.

Neosquamous Epithelium Does Not Typically Arise from Barrett's Epithelium

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2006, Clinical Cancer Research.

Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation

C. Maley, P. Blount, B. Reid, 2006, Cancer Epidemiology Biomarkers & Prevention.

Flow cytometric enrichment for respiratory epithelial cells in sputum

Carissa A. Sanchez, J. Jett, B. Reid, 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

A. Kristal, P. Blount, B. Reid, 2003, Journal of the National Cancer Institute.

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Patricia L. Blount, A. Kristal, P. Blount, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Nonsteroidal Anti-inflammatory Drug Use , Body Mass Index , and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett ’ s Esophagus 1

A. Kristal, P. Blount, B. Reid, 2002 .

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2001, American Journal of Gastroenterology.

p53-mutant clones and field effects in Barrett's esophagus.

B. Reid, P. Galipeau, C. Sanchez, 1999, Cancer research.

Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms.

Carissa A. Sanchez, M. Emond, M. Barrett, 1996, Oncogene.

p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia.

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 1994, Gastroenterology.

17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 1994, Cancer research.

NSAID use and somatic exomic mutations in Barrett’s esophagus

J. Delrow, B. Reid, M. Kuhner, 2018, Genome Medicine.

Within‐patient phylogenetic reconstruction reveals early events in Barrett’s Esophagus

Lucian P. Smith, B. Reid, M. Kuhner, 2020, Evolutionary applications.

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus

Patricia L. Blount, C. Maley, P. Blount, 2015, Cancer Prevention Research.

p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2008, PloS one.

Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma

Carissa A. Sanchez, Patricia L. Blount, C. Maley, 2009, Clinical Cancer Research.

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.

Carissa A. Sanchez, Patricia L. Blount, Linda M. Dong, 2005, The Lancet. Oncology.

Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus

K. Gunderson, D. Peiffer, C. Maley, 2010, Molecular Cancer Research.

Inactivation of p53 and the Development of Tetraploidy in the Elastase‐SV40 T Antigen Transgenic Mouse Pancreas

Carissa A. Sanchez, B. Reid, C. Sanchez, 1995, Pancreas.

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett’s Esophagus Cohort

Brian C. Claywell, Patricia L. Blount, Frederick Albert Matsen IV, 2015, PloS one.

Crypt Dysplasia With Surface Maturation: A Clinical, Pathologic, and Molecular Study of a Barrett's Esophagus Cohort

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2006, The American journal of surgical pathology.

Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.

B. Reid, P. Rabinovitch, D. Levine, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Barrett's esophagus: ordering the events that lead to cancer.

M. Barrett, B. Reid, D. Levine, 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett’s Esophagus

Patricia L. Blount, P. Blount, B. Reid, 2015, PloS one.

Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues.

Ziding Feng, Jane A Dickerson, B. Reid, 2006, Analytical chemistry.

Barrett's Esophagus and Esophageal Adenocarcinoma Epigenetic Biomarker Discovery Using Infinium ® Methylation

B. Reid, D. Chao, P. Galipeau, 2008 .

Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.

P. Blount, B. Reid, P. Rabinovitch, 1992, Gastroenterology.

Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria

Martin T. Suchorolski, Carissa A. Sanchez, B. Reid, 2013, PloS one.

Feasibility of RNA and DNA Extraction from Fresh Pipelle and Archival Endometrial Tissues for Use in Gene Expression and SNP Arrays

B. Reid, E. Swisher, S. Reed, 2013, Obstetrics and gynecology international.

Neoplastic Progression in Barrett’s Esophagus

Carissa A. Sanchez, M. Barrett, B. Reid, 1997 .

Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels

P. Martinez, C. Maley, B. Reid, 2018, Nature Communications.

A p53-dependent mouse spindle checkpoint

Carissa A. Sanchez, B. Reid, R. Idzerda, 1995, Science.

NSAID use and somatic exomic mutations in Barrett’s esophagus

Thomas L. Vaughan, Mary K. Kuhner, Carissa A. Sanchez, 2018, Genome Medicine.

Barrett's esophagus: a model of human neoplastic progression.

B. Reid, D. Levine, P. Galipeau, 1994, Cold Spring Harbor symposia on quantitative biology.

Original contributionPredictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

P. Blount, B. Reid, P. Rabinovitch, 2001 .

Nsaids Modulate Cdkn2a, Tp53, and Dna Content Risk for Progression to Esophageal Adenocarcinoma Nsaids Modulate Cdkn2a, Tp53, and Dna Content Risk for Progression to Esophageal Adenocarcinoma Methods and Findings

Carissa A. Sanchez, Patricia L. Blount, R. Odze, 2022 .